• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Fuwei Films (Holdings) Co. Ltd.

    6/29/23 4:01:50 PM ET
    $FFHL
    Specialty Chemicals
    Industrials
    Get the next $FFHL alert in real time by email
    S-8 1 ea180915-s8_baijiayun.htm REGISTRATION STATEMENT

    As filed with the Securities and Exchange Commission on June 29, 2023

    Registration No. 333-          

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM S-8

     

    REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

     

    Baijiayun Group Ltd

    (Exact name of registrant as specified in its charter)

     

    Cayman Islands   Not Applicable
    (State or other jurisdiction of   (I.R.S. Employer
    incorporation or organization)   Identification No.)

     

    24F, A1 South Building, No. 32 Fengzhan Road

    Yuhuatai District, Nanjing 210000

    The People’s Republic of China

    Tel: (86)-25 8222-1596

    (Address of Principal Executive Offices and Zip Code)

     

    2023 Share Incentive Plan

    (Full title of the plan)

     

    Cogency Global Inc.

    122 East 42nd Street, 18th Floor

    New York, NY 10168

    (800) 221-0102

    (Name, address and telephone number, including area code, of agent for service)

     

    Copies to:

     

    Gangjiang Li
    Chairman and Chief Executive Officer
    24F, A1 South Building, No. 32 Fengzhan Road

    Yuhuatai District, Nanjing 210000

    The People’s Republic of China
    Tel: (86)-25 8222-1596

      Dan Ouyang, Esq.
      Wilson Sonsini Goodrich & Rosati
      Professional Corporation
      Unit 2901, 29F, Tower C, Beijing Yintai Centre
      No. 2 Jianguomenwai Avenue
      Chaoyang District, Beijing 100022
      People’s Republic of China
      Tel: (86) 10-6529-8300

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ☐ Accelerated filer ☒
    Non-accelerated filer ☐ Smaller reporting company ☐
        Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

     

     

     

     

     

     

    PART I

     

    INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

     

    Item 1. Plan Information*

     

    Item 2. Registrant Information and Employee Plan Annual Information*

     

    * Information required by Part I to be contained in the Section 10(a) prospectus is omitted from this registration statement in accordance with Rule 428 under the Securities Act and the introductory note to Part I of Form S-8. In accordance with the rules and regulations of the Securities and Exchange Commission (the “Commission”) and the instructions to Form S-8, such documents are not being filed with the Commission either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424. The documents containing information specified in this Part I will be separately provided to the participants covered by the Plan, as specified by Rule 428(b)(1) under the Securities Act.

     

    1

     

     

    PART II

     

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

     

    Item 3. Incorporation of Documents by Reference

     

    The following documents previously filed by Baijiayun Group Ltd (the “Registrant”) with the Commission are incorporated by reference herein:

     

    (a)

    The annual report of the predecessor of the Registrant, Fuwei Films (Holdings) Co., Ltd., on Form 20-F (File No. 001-33176) filed with the Commission on April 28, 2022, which includes audited financial statements of Fuwei Films (Holdings) Co., Ltd. for the three years ended December 31, 2021;

       
    (b)

    The Registrant’s transition report on Form 20-F (File No. 001-33176) filed with the Commission on January 20, 2023, which includes audited financial statements of Baijiayun Limited for the three fiscal years ended June 30, 2022; and

       
    (c) The description of the Registrant’s Class A ordinary shares as contained in Exhibit 2.2 to the Registrant’s transition report on Form 20-F (File No. 001-33176) filed with the Commission on January 20, 2023.

     

    All documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), after the date of this registration statement and prior to the filing of a post-effective amendment to this registration statement which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this registration statement and to be part hereof from the date of filing of such documents. Any statement in a document incorporated or deemed to be incorporated by reference in this registration statement will be deemed to be modified or superseded to the extent that a statement contained in this registration statement or in any other later filed document that also is or is deemed to be incorporated by reference modifies or supersedes such statement. Any such statement so modified or superseded will not be deemed, except as so modified or superseded, to be a part of this registration statement.

      

    Item 4. Description of Securities

     

    Not applicable.

     

    Item 5. Interests of Named Experts and Counsel

     

    Not applicable.

      

    Item 6. Indemnification of Directors and Officers

     

    Cayman Islands law does not limit the extent to which a company’s articles of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against fraud or dishonesty.

     

    The second amended and restated articles of association of the Registrant provide that each officer or director of the Registrant shall be indemnified out of its assets and profits against all actions, costs, charges, losses, damages and expenses incurred or sustained by such director or officer, by or by reason of any act done, concurred in or omitted in or about the execution of their duty, or supposed duty, in their respective offices or trusts, other than by reason of such person’s own dishonesty or fraud.

     

    Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling the Registrant pursuant to the foregoing provisions, the Registrant has been informed that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

     

    II-1

     

     

    Item 7. Exemption from Registration Claimed

     

    Not applicable.

     

    Item 8. Exhibits

     

    See the Exhibit Index attached hereto.

     

    Item 9. Undertakings

     

    (a) The undersigned Registrant hereby undertakes:

     

      (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

     

      (i) to include any prospectus required by Section 10(a)(3) of the Securities Act;

     

      (ii) to reflect in the prospectus any facts or events arising after the effective date of this registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this registration statement; and

     

      (iii) to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to that information in the registration statement;

     

    provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this registration statement;

     

      (2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

      (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

     

    (b) The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     

    (c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

     

    II-2

     

     

    EXHIBIT INDEX

     

    Exhibit
    Number
      Description
    4.1   Third Amended and Restated Memorandum of Association and Second Amended and Restated Articles of Association, as currently in effect (incorporated by reference to Exhibit 1.1 to the Registrant’s transition report on Form 20-F filed with the Commission on January 20, 2023)
    4.2   Registrant’s Specimen Certificate for Class A Ordinary Shares (incorporated by reference to Exhibit 2.1 to the Registrant’s transition report on Form 20-F filed with the Commission on January 20, 2023)
    5.1*   Opinion of Conyers Dill & Pearman regarding the validity of the Class A ordinary shares being registered
    10.1   2023 Share Incentive Plan (incorporated by reference to Exhibit 10.8 to the Registrant’s registration statement on Form F-1 initially filed with the Commission on March 27, 2023, as amended)
    23.1*   Consent of MaloneBailey, LLP
    23.2*   Consent of Friedman LLP
    23.3*   Consent of Shandong Haoxin Certified Public Accountants Co., Ltd.
    23.4*   Consent of Conyers Dill & Pearman (included in Exhibit 5.1)
    24.1*   Powers of Attorney (included on signature page hereto)
    107*   Filing Fee Table

     

    *Filed herewith.

     

    II-3

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Nanjing, China, on June 29, 2023.

     

      Baijiayun Group Ltd
       
      By: /s/ Gangjiang Li
        Name:  Gangjiang Li
        Title: Chairman and Chief Executive Officer

     

    II-4

     

     

    POWER OF ATTORNEY

     

    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below does hereby constitute and appoint Mr. Gangjiang Li, as his or her true and lawful attorney-in-fact and agent, each with full power of substitution and re-substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration statement and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent may lawfully do or cause to be done by virtue hereof.

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement has been signed by the following persons on June 29, 2023 in the capacities indicated.

     

    Signature   Title
         
    /s/ Gangjiang Li  

    Chairman and Chief Executive Officer

    Gangjiang Li   (Principal Executive Officer)
         
    /s/ Yong Fang   Chief Financial Officer
    Yong Fang   (Principal Financial and Accounting Officer)
         
    /s/ Yi Ma   Director and President
    Yi Ma    
         
    /s/ Chun Liu   Director
    Chun Liu    
         
    /s/ Erlu Lin   Director
    Erlu Lin    
         
    /s/ Ching Chiu   Director
    Ching Chiu    

     

    II-5

     

     

    SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES

     

    Pursuant to the Securities Act of 1933, as amended, the undersigned, the duly authorized representative in the United States of Baijiayun Group Ltd has signed this registration statement or amendment thereto in New York on June 29, 2023.

     

      COGENCY GLOBAL INC.
      Authorized U.S. Representative
         
      By: /s/ Colleen A. De Vries
        Name:  Colleen A. De Vries
        Title: Senior Vice President on behalf of Cogency Global Inc.

     

     

     

    II-6

     

     

    Get the next $FFHL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FFHL

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FFHL
    SEC Filings

    View All

    SEC Form 6-K filed by Fuwei Films (Holdings) Co. Ltd.

    6-K - Baijiayun Group Ltd (0001381074) (Filer)

    1/22/24 7:35:53 AM ET
    $FFHL
    Specialty Chemicals
    Industrials

    SEC Form 20-F filed by Fuwei Films (Holdings) Co. Ltd.

    20-F - Baijiayun Group Ltd (0001381074) (Filer)

    1/16/24 4:37:53 PM ET
    $FFHL
    Specialty Chemicals
    Industrials

    SEC Form 6-K filed by Fuwei Films (Holdings) Co. Ltd.

    6-K - Baijiayun Group Ltd (0001381074) (Filer)

    11/17/23 8:30:02 AM ET
    $FFHL
    Specialty Chemicals
    Industrials

    $FFHL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Baijiayun Group Ltd Completes Transition into a Pure-play RTC Provider with Divestiture of Fuwei Films

    BEIJING, March 13, 2023 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ:RTC), a video-centric technology solution provider with core expertise in SaaS/PaaS solutions, today announced that on March 9, 2023, it entered into a securities purchase agreement (the "SPA") with Aoji Holdings Co., Ltd ("Aoji" or the "Purchaser") to divest the Company's 100% equity ownership in Fuwei Films (BVI) Co., Ltd. for a cash consideration of US$30 million (the "Transaction"). The closing of the Transaction is expected to take place by the end of March 2023 (the "Closing Date"), subject to the satisfaction of closing conditions set forth in the SPA. The completion of the Transaction m

    3/13/23 4:30:00 PM ET
    $RTC
    $FFHL
    Computer Software: Prepackaged Software
    Technology
    Specialty Chemicals
    Industrials

    Baijiayun Group Ltd Announces Change in Nasdaq Ticker Symbol to "RTC" Post Completion of Merger

    BEIJING, Dec. 30, 2022 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ:FFHL) today announced that it will change its ticker symbol on the Nasdaq Capital Market from "FFHL" to "RTC." Trading under the new ticker symbol will begin at market opening on Friday, December 30, 2022. Baijiayun announced the successful completion of the merger transaction (the "Transaction") between Baijiayun Limited and Fuwei Films (Holdings) Co., Ltd. ("Fuwei Films") and the appointment of a new board and management team on December 23, 2022. The Transaction was previously announced on July 19, 2022, and subsequently approved by the shareholders of Fuwei Films at an extraordinary general

    12/30/22 8:30:00 AM ET
    $FFHL
    Specialty Chemicals
    Industrials

    BaiJiaYun Limited Announces Completion of Merger and New Board and Management

    BEIJING, Dec. 23, 2022 /PRNewswire/ -- BaiJiaYun Limited ("BaiJiaYun") today announced the successful completion of the transaction (the "Transaction") previously announced on July 19, 2022 between BaiJiaYun and Fuwei Films (Holdings) Co., Ltd. ("Fuwei Films" or the "Company"). As announced on September 26, 2022, the Transaction and certain additional Transaction-related proposals were approved by Fuwei Films' shareholders at an extraordinary general meeting held on September 24, 2022 (the "EGM"). Among such proposals, the Company's name will be changed from "Fuwei Films (Holdings) Co., Ltd." to " Baijiayun Group Ltd". The Company continues to be listed on Nasdaq and its ticker is expected t

    12/23/22 4:15:00 PM ET
    $FFHL
    Specialty Chemicals
    Industrials

    $FFHL
    Leadership Updates

    Live Leadership Updates

    View All

    Baijiayun Group Ltd Announces Change in Nasdaq Ticker Symbol to "RTC" Post Completion of Merger

    BEIJING, Dec. 30, 2022 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ:FFHL) today announced that it will change its ticker symbol on the Nasdaq Capital Market from "FFHL" to "RTC." Trading under the new ticker symbol will begin at market opening on Friday, December 30, 2022. Baijiayun announced the successful completion of the merger transaction (the "Transaction") between Baijiayun Limited and Fuwei Films (Holdings) Co., Ltd. ("Fuwei Films") and the appointment of a new board and management team on December 23, 2022. The Transaction was previously announced on July 19, 2022, and subsequently approved by the shareholders of Fuwei Films at an extraordinary general

    12/30/22 8:30:00 AM ET
    $FFHL
    Specialty Chemicals
    Industrials

    Fuwei Films Announces Results of 2021 Annual General Meeting of Shareholders

    BEIJING, Dec. 30, 2021 /PRNewswire/ -- Fuwei Films (Holdings) Co., Ltd. (NASDAQ:FFHL) ("Fuwei Films" or the "Company"), a manufacturer and distributor of high-quality BOPET plastic films in China, today announced the results of its Annual General Meeting of Shareholders (the "Meeting"), which was held on December 30, 2021 at 10:00 a.m. (Beijing Time), at Fuwei Films (Shandong) Co., Ltd., No. 387 Dongming Road, Weifang, Shandong, China. Holders of 73.62% of the Company's outstanding ordinary shares, as of the record date, November 19, 2021, were present in person or represented by proxy at the Meeting and approved the re-election of Mr. Junying Liu, and ratified the appointment of Shandong H

    12/30/21 8:30:00 AM ET
    $FFHL
    Specialty Chemicals
    Industrials

    $FFHL
    Financials

    Live finance-specific insights

    View All

    Fuwei Shareholder Receives Partial Waiver Regarding Lock-up

    BEIJING, Oct. 7, 2022 /PRNewswire/ -- Fuwei Films (Holdings) Co., Ltd. (NASDAQ:FFHL) ("Fuwei Films" or the "Company"), a manufacturer and distributor of high-quality BOPET plastic films in China, today announced that BaiJiaYun Limited ("BaiJiaYun") entered into a letter with Apex Glory Holdings Limited ("Apex") on October 6, 2022 (the "Letter"), exempting Apex from limitations on disposition with respect to certain equity securities held by it in Fuwei Films as set forth in the lock-up agreement (the "Lock-up Agreement") dated July 18, 2022 entered into by and between BaiJiaYun and Apex. As disclosed in the Schedule 13D/A filed on July 19, 2022 and the proxy statement filed on August 22, 202

    10/7/22 4:15:00 PM ET
    $FFHL
    Specialty Chemicals
    Industrials

    Fuwei Films Announces Fourth Quarter and Full Year 2021 Financial Results

    BEIJING, April 28, 2022 /PRNewswire/ -- Fuwei Films (Holdings) Co., Ltd. (NASDAQ:FFHL) ("Fuwei Films" or the "Company"), a manufacturer and distributor of high-quality BOPET plastic films in China, today announced its financial results for the fourth quarter and full year ended December 31, 2021. 4Q 2021 Highlights Net revenues were RMB92.6 million or US$14.5 millionSales of specialty films were RMB71.1 million or US$11.2 million, up 14.1% year-over-yearGross margin was 30.8%, down from 42.2% a year agoNet income attributable to the Company was RMB11.4 million or US$1.8 millionBasic and diluted earnings per share was RMB3.48 or US$0.55Full Year 2021 Highlights Net revenues were RMB396.8 mi

    4/28/22 4:35:00 PM ET
    $FFHL
    Specialty Chemicals
    Industrials

    Fuwei Films Announces Its Unaudited Financial Results for the Second Quarter of 2021

    -Teleconference to be Held on Friday, September 3, 2021 at 8:00 am ET- BEIJING, Sept. 2, 2021 /PRNewswire/ -- Fuwei Films (Holdings) Co., Ltd. (NASDAQ:FFHL) ("Fuwei Films" or the "Company"), a manufacturer and distributor of high-quality BOPET plastic films in China, today announced its unaudited financial results for the second quarter and first six months of 2021 ended June 30, 2021. Second Quarter 2021 Financial Highlights Net sales were RMB100.6 million (US$15.6 million), compared to RMB82.9 million during the same period in 2020, representing a year-over-year increase of RMB17.7 million or 21.4%. Sales of specialty films were RMB69.0 million (US$10.7 million) or 68.6% of our total rev

    9/2/21 4:15:00 PM ET
    $FFHL
    Specialty Chemicals
    Industrials

    $FFHL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Fuwei Films (Holdings) Co. Ltd. (Amendment)

    SC 13G/A - Baijiayun Group Ltd (0001381074) (Subject)

    2/13/23 1:18:37 PM ET
    $FFHL
    Specialty Chemicals
    Industrials

    SEC Form SC 13D/A filed by Fuwei Films (Holdings) Co. Ltd. (Amendment)

    SC 13D/A - Fuwei Films (Holdings), Co. Ltd. (0001381074) (Subject)

    12/6/22 4:01:43 PM ET
    $FFHL
    Specialty Chemicals
    Industrials

    SEC Form SC 13D/A filed by Fuwei Films (Holdings) Co. Ltd. (Amendment)

    SC 13D/A - Fuwei Films (Holdings), Co. Ltd. (0001381074) (Subject)

    10/7/22 4:01:19 PM ET
    $FFHL
    Specialty Chemicals
    Industrials